WO2002007723A1 - Compositions pour réguler le désir de fumer - Google Patents

Compositions pour réguler le désir de fumer Download PDF

Info

Publication number
WO2002007723A1
WO2002007723A1 PCT/JP2001/006202 JP0106202W WO0207723A1 WO 2002007723 A1 WO2002007723 A1 WO 2002007723A1 JP 0106202 W JP0106202 W JP 0106202W WO 0207723 A1 WO0207723 A1 WO 0207723A1
Authority
WO
WIPO (PCT)
Prior art keywords
smoking
desire
compositions
regulating
intended
Prior art date
Application number
PCT/JP2001/006202
Other languages
English (en)
French (fr)
Inventor
Tsutomu Okubo
Makoto Ozeki
Takehiko Inden
Lekh Raj Juneja
Masahiko Hisanabe
Ken-Ichi Okayama
Original Assignee
Taiyo Kagaku Co., Ltd.
Otsuka Chemical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiyo Kagaku Co., Ltd., Otsuka Chemical Co., Ltd. filed Critical Taiyo Kagaku Co., Ltd.
Priority to AU2452502A priority Critical patent/AU2452502A/xx
Priority to AU2002224525A priority patent/AU2002224525B2/en
Priority to EP01984301A priority patent/EP1319401A4/en
Priority to KR10-2003-7000838A priority patent/KR100516341B1/ko
Priority to MXPA03000600A priority patent/MXPA03000600A/es
Priority to CA002385415A priority patent/CA2385415C/en
Priority to US10/088,587 priority patent/US7094787B2/en
Publication of WO2002007723A1 publication Critical patent/WO2002007723A1/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Confectionery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
PCT/JP2001/006202 2000-07-21 2001-07-18 Compositions pour réguler le désir de fumer WO2002007723A1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
AU2452502A AU2452502A (en) 2000-07-21 2001-07-18 Compositions for regulating desire for smoking
AU2002224525A AU2002224525B2 (en) 2000-07-21 2001-07-18 Compositions for regulating desire for smoking
EP01984301A EP1319401A4 (en) 2000-07-21 2001-07-18 COMPOSITIONS FOR CONTROLLING THE DESIRE TO SMOKE
KR10-2003-7000838A KR100516341B1 (ko) 2000-07-21 2001-07-18 흡연 욕구 억제 조성물
MXPA03000600A MXPA03000600A (es) 2000-07-21 2001-07-18 Composiciones para regular el deseo de fumar.
CA002385415A CA2385415C (en) 2000-07-21 2001-07-18 Compositions for regulating desire for smoking
US10/088,587 US7094787B2 (en) 2000-07-21 2001-07-18 Compositions for regulating desire for smoking

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2000220301 2000-07-21
JP2000-220301 2000-07-21
JP2001-34460 2001-02-09
JP2001034460A JP3730522B2 (ja) 2000-07-21 2001-02-09 喫煙欲求抑制組成物

Publications (1)

Publication Number Publication Date
WO2002007723A1 true WO2002007723A1 (fr) 2002-01-31

Family

ID=26596393

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2001/006202 WO2002007723A1 (fr) 2000-07-21 2001-07-18 Compositions pour réguler le désir de fumer

Country Status (9)

Country Link
US (1) US7094787B2 (ja)
EP (1) EP1319401A4 (ja)
JP (1) JP3730522B2 (ja)
KR (1) KR100516341B1 (ja)
CN (1) CN1273126C (ja)
AU (2) AU2002224525B2 (ja)
CA (1) CA2385415C (ja)
MX (1) MXPA03000600A (ja)
WO (1) WO2002007723A1 (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10035190C5 (de) 2000-07-20 2009-07-16 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren und Vorrichtung zur Fluoreszenzmessung
BRPI0517122A (pt) * 2004-12-08 2008-09-30 Unilever Nv composição, seu uso e método para a melhora da concentração do foco mental e/ou da disposição
JP4709120B2 (ja) * 2006-10-23 2011-06-22 株式会社 伊藤園 成長ホルモン分泌促進用組成物
US8945655B2 (en) * 2007-07-10 2015-02-03 Conopco, Inc. Stable and consumable compositions
US20090155420A1 (en) * 2007-12-12 2009-06-18 Conopco, Inc., D/B/A Unilever Food product with stabilized non-protein amino acids
RU2613018C2 (ru) * 2008-09-17 2017-03-14 Ионглин ЛИАНГ Фильтр для избавления от табакозависимости и детоксикации, мундштук для сигарет и способ их изготовления
JP2012507993A (ja) * 2008-11-11 2012-04-05 ユニリーバー・ナームローゼ・ベンノートシヤープ 茶組成物
CA2776160A1 (en) * 2009-09-30 2011-04-07 Harlan Clayton Bieley Smoking cessation with body weight maintenance and nutritional supplement
JP6300154B2 (ja) * 2014-03-14 2018-03-28 ハウスウェルネスフーズ株式会社 スターアニス抽出物含有飲料
CN103933108A (zh) * 2014-03-20 2014-07-23 马国云 黄秋葵叶戒烟茶及其生产工艺
RU2572720C1 (ru) * 2014-07-29 2016-01-20 Дмитрий Евгеньевич Денисов Комплексное антиникотиновое средство
US11102994B2 (en) 2014-08-21 2021-08-31 Clearfast Inc. Pre-operative carbohydrate-rich beverage composition and methods of treatment
CA3208235A1 (en) 2015-08-31 2017-03-09 Nutramax Laboratories, Inc. Compositions comprising magnolia, phellodendron, theanine and/or whey protein
CN105194023A (zh) * 2015-09-18 2015-12-30 苟春虎 高级戒烟含片
KR102147592B1 (ko) 2019-01-28 2020-08-24 동리 쉔 흡연 억제용 조성물 및 이를 함유하는 건강기능식품
BG67408B1 (bg) 2019-04-12 2022-01-17 Софарма Ад Перорален лекарствен състав с растителен алкалоид, за лечение на зависимости
US11969502B2 (en) * 2019-12-09 2024-04-30 Nicoventures Trading Limited Oral products
US11872231B2 (en) 2019-12-09 2024-01-16 Nicoventures Trading Limited Moist oral product comprising an active ingredient
CN114230738A (zh) * 2021-12-14 2022-03-25 南方海洋科学与工程广东省实验室(湛江) 一种自降解的阳离子聚合物及其制备方法与应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06100442A (ja) * 1992-09-17 1994-04-12 Suntory Ltd 抗ストレス剤
JPH0912454A (ja) * 1995-06-27 1997-01-14 Taiyo Kagaku Co Ltd テアニン含有組成物
WO1999042096A1 (fr) * 1998-02-23 1999-08-26 Taiyo Kagaku Co., Ltd. Composition renfermant de la theanine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA726026B (en) 1971-12-23 1973-05-30 D Woodcraft Anti-smoking preparation
JPS5731620A (en) 1980-07-30 1982-02-20 Naotake Jiyuunishiyo Candy enabling to give up smoking
JPS60122567A (ja) * 1983-12-08 1985-07-01 高砂香料工業株式会社 消臭・脱臭剤
JPS6163243A (ja) 1984-09-05 1986-04-01 Yakuoo Seiyaku Kk 嫌煙トロ−チ
JPS62296840A (ja) 1986-06-16 1987-12-24 Kozo Atami たばこキヤンデ−およびシガレツトキヤンデ−
JPS6370728A (ja) 1986-09-11 1988-03-30 東急建設株式会社 浸透施設
JP2924099B2 (ja) 1990-06-13 1999-07-26 茂 川瀬 経口節煙剤
US5501866A (en) * 1990-12-02 1996-03-26 Ito En, Ltd. Product and method for inhibiting caffeine stimulation with theanine
JPH05123166A (ja) 1991-10-31 1993-05-21 Food Design Gijutsu Kenkyu Kumiai 茶の培養細胞群の増殖法
JPH05229938A (ja) * 1991-12-25 1993-09-07 Food Design Gijutsu Kenkyu Kumiai 血圧降下剤
CA2119000A1 (en) 1993-03-19 1994-09-20 David Frederick Horrobin Formulation for use in smokers
JPH08308544A (ja) 1995-05-18 1996-11-26 Shimazaki Shiyubiyou Kk 健康茶並びにその製造方法
JP3797627B2 (ja) * 1995-10-03 2006-07-19 株式会社 伊藤園 興奮促進剤
US6132724A (en) * 1998-04-29 2000-10-17 City Of Hope National Medical Center Allelic polygene diagnosis of reward deficiency syndrome and treatment
US7273621B2 (en) 2000-04-05 2007-09-25 Taiyo Kagaku Co., Ltd. Compositions for promoting sleep
EP1275308A1 (en) 2001-07-13 2003-01-15 The Procter & Gamble Company Food composition offering stress relaxation to mammals

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06100442A (ja) * 1992-09-17 1994-04-12 Suntory Ltd 抗ストレス剤
JPH0912454A (ja) * 1995-06-27 1997-01-14 Taiyo Kagaku Co Ltd テアニン含有組成物
WO1999042096A1 (fr) * 1998-02-23 1999-08-26 Taiyo Kagaku Co., Ltd. Composition renfermant de la theanine

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE CAPLUS [online] AMERICAN CHEMICAL SOCIETY (ACS), (COLUM,BUS, OHIO, USA); accession no. STN Database accession no. 118:207370 *
See also references of EP1319401A4 *
YASUHITO ISHIMOTO ET AL.: "The effect of cigarette smoking on the human SEP (somatosensory evoked potential) and EEG", SHIKOKU IGAKU ZASSHI, vol. 49, no. 1, 1993, pages 52 - 70, XP002947261 *

Also Published As

Publication number Publication date
AU2452502A (en) 2002-02-05
JP3730522B2 (ja) 2006-01-05
AU2002224525B2 (en) 2004-07-22
KR20030036619A (ko) 2003-05-09
CN1462188A (zh) 2003-12-17
MXPA03000600A (es) 2004-03-12
EP1319401A4 (en) 2004-02-04
KR100516341B1 (ko) 2005-09-22
CN1273126C (zh) 2006-09-06
CA2385415A1 (en) 2002-01-31
EP1319401A1 (en) 2003-06-18
CA2385415C (en) 2008-01-29
JP2002097136A (ja) 2002-04-02
US7094787B2 (en) 2006-08-22
US20030003130A1 (en) 2003-01-02

Similar Documents

Publication Publication Date Title
WO2002007723A1 (fr) Compositions pour réguler le désir de fumer
AU2003269167A1 (en) Methods of purifying cannabinoids from plant material
BR0104654A (pt) Artigo absorvente
MXPA04005790A (es) Compuestos y usos de los mismos para reducir la actividad de la lipasa sensible a la hormona.
WO2003049689A3 (en) Isoflavone composition for oral delivery
WO1998002148A3 (en) Pharmaceutical composition
WO2002034753A3 (en) Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
WO2001060331A3 (en) Compositions for preventing cellulite in mammalian skin
PL370795A1 (en) Composition based on etyllinoleate and triethylcitrate for the treatment of seborrhea and acne
BR0300301A (pt) Método para afetar comportamentos durante o sono e relacionados ao sono
AU2002218461A1 (en) Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
WO2002005642A3 (en) Synergistic biocidal compositions
AU2002218371A1 (en) Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration
HK1050482A1 (en) Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia 13-hode
WO2002020090A3 (en) Pharmaceutical compositions
WO2008033655A3 (en) Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy
WO2003047511A3 (en) Use of gingko biloba extracts to promote neuroprotection and reduce weight loss
WO2001070233A3 (en) Apoptosis inhibiting composition comprising a 15-keto-prostaglandin or derivative thereof
WO2001085118A3 (en) Antiperspirant and/or deodorant compositions
AU2001264522A1 (en) Methods and compositions for the prevention of myopia
AU6303698A (en) Component of bromelain
AU2002311412A1 (en) Thickened aqueous compositions
WO2005051487A3 (en) A ruminant zinc containing bolus
WO2002022211A3 (en) Reduction of the electrocardiographic ot interval
AU2003294405A1 (en) Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2385415

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 10088587

Country of ref document: US

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)

Free format text: (EXCEPT CA, US)

WWE Wipo information: entry into national phase

Ref document number: 2001984301

Country of ref document: EP

Ref document number: 2002224525

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 97/CHENP/2003

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 1020037000838

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: PA/a/2003/000600

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 018161162

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 1020037000838

Country of ref document: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001984301

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 2002224525

Country of ref document: AU

WWG Wipo information: grant in national office

Ref document number: 1020037000838

Country of ref document: KR